Preliminary data from its 3rd phase of clinical trials indicate that the domestically produced and government-backed Covaxin in India has an efficacy rate of 81%. The use of the Oxford-AstraZeneca vaccine, also known as Covishield, has also been approved in India.
During its clinical trial the vaccine has been injected to approximately 43,538 volunteers of different race, origin & Country., Among this only 10% of then acquired the disease, this becomes the great breakthrough news in this pandemic.
Johnson & Johnson, an American pharmaceutical company, has announced that it will suspend production of the Corona vaccine. Johnson & Johnson said in a statement that the decision was made because one of the volunteers involved in the experiment had fallen ill.